ClinicalTrials.gg
CompletedNCT03149458DanceStudioUpdated Sep 18, 2026

Dance Workshop on Balance of Hemiparetic Patients

An interventional study of dance and control in Hemiparesis, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Centre d'Investigation Clinique et Technologique 805 · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Paresis with a site in France — 12 open to participants now, 12 under way, none of them phase 3. Paresis · France.

Enrollment
16th of 22
31 · median 40
Started
2017
the only one that year
No phase
22 of 26
9 open now
Registered
7th of 26
by date
Lead sponsor
1 of 26
Centre d'Investigation Clinique et Technologique 805

Among the 26 studies in Paresis with a site in France, this one is the 16th largest by enrollment of the 22 interventional ones that give a count, is the only one that started in 2017, is one of 22 with no phase, and was the 7th registered.

Paresis

473 studies on the registry are indexed under Paresis; 121 are open to participants now.

Browse Paresis studies →

Open to participants now

12 of the 26 studies in Paresis with a site in France are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 84 Paresis studies recruiting now, 34 (40%) set no upper age limit and 27 (32%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Paresis with a site in France, or all of them as a file.
02

Study summary

The majority of hemiparetic patients have balance disorders, which impact independence in daily living activities and walking. Conventional techniques used in rehabilitation improve balance but have shown no effects on dynamic balance required during walking. Recently dance is proposed to improve dynamic balance in older people and people with Parkinson's disease. Although many studies showed that dance is an effective activity to improve balance in these people, it has never been assessed in hemiparetic patients (except a case report). The aim of this study is to show that a dance program improves the balance of hemiparetic patients, compared to a control group. This randomized controlled study aims to include 40 hemiparetic patients who will perform a dance program (experimental group) or a upper-limb rehabilitation program (control group) for 8 one-hour sessions.

Read the detailed description

Randomized controlled study aims to include 40 hemiparetic patients who will perform a dance program (experimental group) or a upper-limb rehabilitation program (control group) for 8 one-hour sessions. These activities are carried out in the form of a workshop and are already proposed in common practice in the service. They are carried out by the physiotherapists of the service. Patients are assigned in one of two study groups. It is specified that they will be able to carry out the program of the opposing group at the end of the study in order to limit the "disappointment" effect. The evaluations will be carried out at 4 and 8 weeks and will mainly rely on data of balance, function, quality of life and satisfaction

03

Conditions studied

  • Hemiparesis

Browse trials for

Keywords

  • stroke
  • balance
  • dance
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient who signed the consent letter
  • Male or female adults age ≥ 18 years,
  • Hemiparetic patient
  • Patient with balance disorders, able to walk alone and perform a U-turn, with or without technical assistance.

Exclusion criteria

Exclusion Criteria:

  • Bilateral brain lesions, cerebellar syndrome
  • Other pathology or impairment that may interfere with the study such as visual, cardiovascular or other uncontrolled medical conditions
  • Patient who underwent surgery of the musculoskeletal system in The 6 months prior to inclusion
  • Major cognitive disorders not allowing the dance activity or the passing of evaluations
  • Behavioral disorders not allowing group workshops
  • Pregnant woman, breastfeeding
  • Non-affiliation to a social security scheme (beneficiary or beneficiary)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Dance group

    dance program for 8 one-hour sessions.

    Other: dance

  • Active comparator
    control group

    upper limb rehabilitation for 8 one-hour sessions.

    Other: control

Interventions

  • Otherdance

    dance program

  • Othercontrol

    upper limb rehabilitation

06

What researchers measure

Primary outcomes

  1. Timed up and Go

    get up, walk 3m, turn around and return sit down

    Time frame: 5min

Secondary outcomes

  1. Berg Balance Scale

    clinical scale assessing balance. 14-item scale designed to measure balance of the older adult in a clinical setting. Scoring: A five-point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 56

    Time frame: 10min

07

Study locations

1 site
  • Raymond Poincaré Hospital- PMR Unit - Netter
    Garches, 92380, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2017 to primary completion in Jul 2022, 64 months.

Of 223 non-industry interventional studies with no phase under Paresis, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 55. This study's 64 months is above that.

Counting every sponsor, half of 241 studies reached it within 32 months; a quarter within 13 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2017
First posted
May 11, 2017
StartActual
Mar 15, 2017
Primary completionActual
Jul 20, 2022
CompletionActual
Jul 8, 2025
Last update
Sep 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03149458
Lead sponsor
Centre d'Investigation Clinique et Technologique 805
Collaborators
Fondation Garches
Responsible party
Sponsor
First posted
May 11, 2017
Start date
Mar 15, 2017
Primary completion
Jul 20, 2022
Completion
Jul 8, 2025
Last update
Sep 18, 2026

Study contacts

François GENET, PhD
principal investigator · Centre d'Investigation Clinique et Technologique 805

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion